Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity
Authors
Keywords
-
Journal
JOURNAL OF HUMAN GENETICS
Volume 58, Issue 6, Pages 346-352
Publisher
Springer Nature
Online
2013-05-16
DOI
10.1038/jhg.2013.42
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacogenetics, enzyme probes and therapeutic drug monitoring as potential tools for individualizing taxane therapy
- (2013) Stefanie D Krens et al. PHARMACOGENOMICS
- Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed
- (2013) H. L. McLeod SCIENCE
- Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer
- (2013) Renling Pei et al. Frontiers of Medicine
- Regulatory Polymorphisms in -Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy
- (2012) L. J. Leandro-Garcia et al. CLINICAL CANCER RESEARCH
- Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative
- (2012) A.-M. Tsimberidou et al. CLINICAL CANCER RESEARCH
- The Relationship between Drug Clearance and Body Size
- (2012) Sarah C. McLeay et al. CLINICAL PHARMACOKINETICS
- Analytical Performance of a Real-time PCR-based Assay for V600 Mutations in the BRAF Gene, Used as the Companion Diagnostic Test for the Novel BRAF Inhibitor Vemurafenib in Metastatic Melanoma
- (2012) Harkanwal Halait et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11
- (2012) Afshan Siddiq et al. HUMAN MOLECULAR GENETICS
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Linking abnormal mitosis to the acquisition of DNA damage
- (2012) Neil J. Ganem et al. JOURNAL OF CELL BIOLOGY
- Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal Cancer
- (2012) E. Theodoratou et al. JNCI-Journal of the National Cancer Institute
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase I Study of Infusional 5-Fluorouracil, Leucovorin, Oxaliplatin and Irinotecan in Japanese Patients with Advanced Colorectal Cancer Who Harbor UGT1A1*1/*1,*1/*6 or *1/*28
- (2012) Yu Sunakawa et al. ONCOLOGY
- Genome Sequencing Identifies a Basis for Everolimus Sensitivity
- (2012) G. Iyer et al. SCIENCE
- Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)
- (2011) Lara E. Sucheston et al. BREAST CANCER RESEARCH AND TREATMENT
- A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer
- (2011) E Marcuello et al. BRITISH JOURNAL OF CANCER
- SPA-1 controls the invasion and metastasis of human prostate cancer
- (2011) Yosuke Shimizu et al. CANCER SCIENCE
- Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms
- (2011) Taroh Satoh et al. CANCER SCIENCE
- Pharmacokinetic and Pharmacogenetic Predictive Markers of Irinotecan Activity and Toxicity
- (2011) Antonello Di Paolo et al. CURRENT DRUG METABOLISM
- The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phase
- (2011) Emiel Rutgers et al. EUROPEAN JOURNAL OF CANCER
- Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
- (2011) David Neal Franz Expert Review of Anticancer Therapy
- Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
- (2011) Da Yang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A1*28/*6 Polymorphisms
- (2011) Y. Okuyama et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesis
- (2011) Evan J Begg et al. PHARMACOGENOMICS
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients
- (2010) Kimie Sai et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on theUGT1A1*28polymorphism
- (2009) Shoichi Hazama et al. CANCER SCIENCE
- Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?
- (2009) GENETICS IN MEDICINE
- Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics
- (2009) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer
- (2009) Giuseppe Toffoli et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- The Staging of Cancer: A Retrospective and Prospective Appraisal
- (2008) F. L. Greene et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
- (2008) B. S. Wittner et al. CLINICAL CANCER RESEARCH
- Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan
- (2008) N Yamamoto et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Close Association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 Haplotype and Its Apparent Influence on 7-Ethyl-10-hydroxycamptothecin (SN-38) Glucuronidation in Japanese
- (2008) Y. Saito et al. DRUG METABOLISM AND DISPOSITION
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
- (2008) L. Meikle et al. JOURNAL OF NEUROSCIENCE
- Bromodomain 4 activation predicts breast cancer survival
- (2008) N. P. S. Crawford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search